Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Chronic Asthma

Condition:   Asthma
Intervention:   Drug: Laninamivir octanoate
Sponsors:   Biota Scientific Management Pty Ltd;   Department of Health and Human Services
Recruiting – verified December 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.